Managing Misfolded Proteins to Prevent Parkinson’s Disease
In a new team science project funded by Aligning Science Across Parkinson’s (ASAP), Yale School of Medicine researchers hope to shed new light on what happens to alpha-synuclein in between nerve cells—and what determines where it ends up. To try to find that balance, Strittmatter and colleagues plan to approach the problem from different angles.
